Not a healthcare professional? Go to the patient or caregiver website.

ZINECARD®Patient Counseling Information (dexrazoxane)

17 PATIENT COUNSELING INFORMATION

17.1 Myelosuppression

Treatment with ZINECARD is associated with leukopenia, neutropenia, and thrombocytopenia. Perform hematological monitoring [see Warnings and Precautions (5.1)].

17.2 Embryo-Fetal Toxicity

Counsel patients on pregnancy planning and prevention. Advise female patients of reproductive potential that ZINECARD can cause fetal harm and to use highly effective contraception during treatment [see Warnings and Precautions (5.5) and Use in Specific Populations (8.1, 8.6)].

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No